Gladstone NOW: The Campaign Join Us on the Journey✕
316 - 330 of 1257 Results Clear All
Gladstone virologists discuss Omicron and what we might expect in 2022 from the COVID-19 pandemic
Gladstone Experts COVID-19 Greene Lab Ott Lab
Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab Chaturvedi
The method lets researchers more easily study factors that can lead to cell death, in conditions including neurodegenerative diseases
News Release Research (Publication) Center for Systems and Therapeutics
abc7 News—Senior Investigators Warner Greene, MD, PhD, and Nevan Krogan, PhD, discuss the possibility that Omicron, although more transmissible than previous SARS-CoV-2 variants, may cause less severe disease.
Gladstone Experts COVID-19 Center for HIV Cure Research Data Science and Biotechnology Virology Greene Lab Krogan Lab
Gladstone scientist receives highest distinction for academic inventors
Awards News Release Multiple Sclerosis Alzheimer’s Disease Center for Neurovascular Brain Immunology Akassoglou Lab
San Francisco Chronicle—The identification of an individual infected with the Omicron variant of SARS-CoV-2 in San Francisco is helping local scientists assess the danger posed by the virus. Melanie Ott, director of the Gladstone Institute of Virology, explains that experiments using virus samples from that individual could help determine how well the available vaccines hold up to Omicron’s mutations.
Gladstone Experts COVID-19 Virology Ott Lab
Gladstone scientists create novel organoids that open new doors for understanding crosstalk between tissues during human development
News Release Research (Publication) Cardiovascular Disease McDevitt Lab Organoids
Researchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications
Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger Lab Deep Dive
Brain Injury Radio—On a radio show dedicated to traumatic brain injury (TBI), Associate Investigator Jeanne Paz, PhD, explains her life-long interest and current work in TBI and in epilepsy, a common long-term consequence of brain damage.
Gladstone Experts Traumatic Brain Injury Epilepsy Paz Lab
San Francisco Chronicle—The emerging Omicron variant of SARS-CoV-2 features several mutations in its spike protein that in theory could make it resistant to current vaccines. But Associate Investigator Nadia Roan, PhD, explains that current vaccines will still protect against Omicron, as they elicit a variety of antibodies and immune T cells that target non-mutated areas of spike.
Gladstone Experts COVID-19 Virology Roan Lab
ABC News—A new variant of SARS-CoV-2, dubbed Omicron, is causing concern around the world. Gladstone President Deepak Srivastava explains that some of the variant’s 50 mutations may have arisen when an individual who was already immunocompromised became infected with the virus. Senior Investigator Nevan Krogan describes how his group is investigating whether the new mutations will change the ability of the virus to enter cells and cause disease.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Srivastava Lab
Watch recordings from the Gladstone-UCSF Institute of Genomic Immunology Symposium
Gladstone Experts Genomic Immunology Marson Lab Pelka Lab Genomics
NIH Director’s Blog—The Delta variant of SARS-CoV-2 is driving the latest surge of COVID-19 cases in the United States. New research from Senior Investigators Jennifer Doudna and Melanie Ott explains how mutations in this variant increase transmissibility.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab
BioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.
Gladstone Experts Alzheimer’s Disease Neurological Disease Huang Lab
Vijay Ramani, who develops novel tools to study single molecules, joins Gladstone Institutes
Institutional News News Release Profile Data Science and Biotechnology Ramani Lab
